Home > Insider Trading > Filing (0001140361-23-030333)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1559053	Prothena Corp Public Ltd Co	PRTA	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1854126	Hideki Garren	C/O Prothena Biosciences Inc 331 Oyster Point Boulevard South San Francisco CA 94080	Chief Medical Officer	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Ordinary Shares, Par Value $0.01 Per Share	Acquisiton	2023-06-16	7,331	$24.90	7,331	No	4	M	Direct
Ordinary Shares, Par Value $0.01 Per Share	Disposition	2023-06-16	7,331	$74.00	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Ordinary Shares	Stock Option (Right to Buy)	Disposition	2023-06-16	7,331	$0.00	7,331	$24.90

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
198,000		2031-04-05	No	4	M	Direct

Footnotes

The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 16, 2023.
The shares subject to the option vested and became exercisable as to 25% of the total number of shares subject to the option on April 5, 2022, and vest and become exercisable with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.